CONCORDBIO - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 3.2
Show all parameters (20 more)
🧾 Trade Setup
Entry Price: 1,460 ₹ – Initiate a long position now, exploiting the undervaluation relative to its peers. Exit Guidance: Set a stop-loss order at 1,380 ₹, targeting a profit of 115 ₹. Alternatively, consider exiting if the price dips below 1,420 ₹ due to the recent PAT decline and high PEG ratio – this presents a clear risk signal. Verdict: This is a moderately attractive swing trade candidate with a defined risk-reward profile; monitor closely for confirmation of momentum or signs of weakness.
✅ Positive
The stock is currently trading at a relatively low PE compared to its industry, indicating potential undervaluation. Momentum remains positive with the DMA crossing above the 200-day moving average and increasing DII holdings.
⚠️ Limitation
Despite the lower PE ratio, the company’s recent PAT decline of 43.7% quarter-over-quarter raises concerns about future earnings growth. The high PEG Ratio (71.5) further suggests that the stock is richly valued relative to expected growth rates.
🏭 Industry
The pharmaceutical sector currently exhibits moderate bullish sentiment, driven by innovation in drug development and increasing demand for generics. However, recent regulatory changes and pricing pressures are creating headwinds for some companies within the industry.